Free Trial

MiMedx Group (MDXG) Stock Price, News & Analysis

MiMedx Group logo
$6.80 +0.14 (+2.10%)
Closing price 04:00 PM Eastern
Extended Trading
$5.38 -1.42 (-20.81%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MiMedx Group Stock (NASDAQ:MDXG)

Key Stats

Today's Range
$6.61
$6.85
50-Day Range
$5.81
$7.43
52-Week Range
$5.33
$10.14
Volume
1.12 million shs
Average Volume
688,873 shs
Market Capitalization
$1.00 billion
P/E Ratio
25.19
Dividend Yield
N/A
Price Target
$12.50
Consensus Rating
Buy

Company Overview

MiMedx Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

MDXG MarketRank™: 

MiMedx Group scored higher than 76% of companies evaluated by MarketBeat, and ranked 256th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MiMedx Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MiMedx Group has received no research coverage in the past 90 days.

  • Read more about MiMedx Group's stock forecast and price target.
  • Earnings Growth

    Earnings for MiMedx Group are expected to grow by 6.67% in the coming year, from $0.30 to $0.32 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MiMedx Group is 25.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.26.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MiMedx Group is 25.19, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.69.

  • Price to Book Value per Share Ratio

    MiMedx Group has a P/B Ratio of 5.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MiMedx Group's valuation and earnings.
  • Percentage of Shares Shorted

    3.67% of the float of MiMedx Group has been sold short.
  • Short Interest Ratio / Days to Cover

    MiMedx Group has a short interest ratio ("days to cover") of 7.4.
  • Change versus previous month

    Short interest in MiMedx Group has recently increased by 6.60%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MiMedx Group does not currently pay a dividend.

  • Dividend Growth

    MiMedx Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.67% of the float of MiMedx Group has been sold short.
  • Short Interest Ratio / Days to Cover

    MiMedx Group has a short interest ratio ("days to cover") of 7.4.
  • Change versus previous month

    Short interest in MiMedx Group has recently increased by 6.60%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MiMedx Group has a news sentiment score of 1.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for MiMedx Group this week, compared to 3 articles on an average week.
  • Search Interest

    5 people have searched for MDXG on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added MiMedx Group to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MiMedx Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,268,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.70% of the stock of MiMedx Group is held by insiders.

  • Percentage Held by Institutions

    79.15% of the stock of MiMedx Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MiMedx Group's insider trading history.
Receive MDXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MiMedx Group and its competitors with MarketBeat's FREE daily newsletter.

MDXG Stock News Headlines

MDXG MiMedx Group, Inc. - Seeking Alpha
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Director Of MiMedx Group Makes $185K Buy
MIMEDX to Participate in Upcoming Investor Conferences
Zooming In On MiMedx Group's Earnings
See More Headlines

MDXG Stock Analysis - Frequently Asked Questions

MiMedx Group's stock was trading at $9.62 at the beginning of the year. Since then, MDXG shares have decreased by 29.3% and is now trading at $6.80.

MiMedx Group, Inc (NASDAQ:MDXG) issued its earnings results on Wednesday, April, 30th. The company reported $0.06 earnings per share for the quarter, hitting the consensus estimate of $0.06. The company had revenue of $88.21 million for the quarter, compared to the consensus estimate of $86.32 million. MiMedx Group had a net margin of 11.40% and a trailing twelve-month return on equity of 22.70%.
Read the conference call transcript
.

Top institutional shareholders of MiMedx Group include Harbor Capital Advisors Inc. (0.79%). Insiders that own company stock include Joseph H Capper, William Frank Iv Hulse, Rohit Kashyap, Ricci S Whitlow, Robert Benjamin Stein, Kimberly Maersk-Moller, William Lawrence Phelan and Rice Doug.
View institutional ownership trends
.

Shares of MDXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MiMedx Group investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Hawkins (HWKN), Adobe (ADBE) and GE Aerospace (GE).

Company Calendar

Last Earnings
4/30/2025
Today
7/14/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:MDXG
CIK
1376339
Employees
870
Year Founded
N/A

Price Target and Rating

High Price Target
$13.00
Low Price Target
$12.00
Potential Upside/Downside
+83.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.27
Trailing P/E Ratio
25.19
Forward P/E Ratio
22.67
P/E Growth
N/A
Net Income
$42.42 million
Net Margins
11.40%
Pretax Margin
15.47%
Return on Equity
22.70%
Return on Assets
16.77%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
4.70
Quick Ratio
4.13

Sales & Book Value

Annual Sales
$348.88 million
Price / Sales
2.88
Cash Flow
$0.34 per share
Price / Cash Flow
20.10
Book Value
$1.31 per share
Price / Book
5.19

Miscellaneous

Outstanding Shares
147,700,000
Free Float
145,191,000
Market Cap
$1.00 billion
Optionable
Optionable
Beta
1.76
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MDXG) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners